first
line
defens
viral
bacteri
attack
reli
innat
immun
system
detect
nonself
product
mean
specif
surfac
endosom
cytosol
receptor
exampl
bacteri
lipopolysaccharid
lp
sens
tolllik
receptor
tlr
cell
surfac
wherea
viral
rna
sens
endosom
cytosol
retinoid
acidinduc
gene
rigi
major
output
receptor
activ
transcript
factor
belong
nuclear
factorkappa
b
nfkb
interferon
ifn
regulatori
factor
irf
famili
control
express
multipl
immun
regulatori
gene
review
focu
nfkb
whose
activ
involv
specif
member
inhibitor
kb
ikb
kinas
ikk
famili
canon
ikk
ikka
ikkb
form
complex
adaptor
protein
nemo
also
known
ikkg
regulatori
role
ikk
complex
requir
proper
nfkb
signal
respons
multipl
proinflammatori
stimuli
tnf
tlr
ligand
ikka
ikkb
serthr
kinas
phosphoryl
nfkb
inhibitor
protein
ikba
result
polyubiquitin
subsequ
proteasom
degrad
allow
nfkb
transloc
nucleu
bind
specif
dna
element
ikka
ikkb
contain
ntermin
catalyt
kinas
domain
kd
central
leucin
zipper
lz
helix
loop
helix
hlh
domain
ctermin
nemobind
domain
nbd
fig
major
impact
ikk
nfkb
signal
inspir
mani
research
search
intens
ikkrel
kinas
base
sequenc
similar
ikka
ikkb
two
ikkrel
kinas
tank
bind
kinas
ikk
also
known
ikkinduc
ikki
discov
ikk
known
noncanon
ikk
expand
ikk
famili
four
member
kinas
domain
ikk
share
amino
acid
ident
correspond
domain
ikka
ikkb
respect
furthermor
ikk
similar
domain
composit
canon
ikk
ikkb
noncanon
ikk
also
share
ubiquitinlik
domain
uld
requir
optim
kinas
activ
importantli
ikk
lack
nbd
interact
nemo
form
similar
complex
specif
scaffold
protein
see
section
although
ikk
origin
classifi
ikk
base
abil
phosphoryl
ikba
upon
overexpress
studi
ikk
defici
cell
reveal
kinas
dispens
ikba
phosphoryl
instead
kinas
shown
contribut
lpsand
virusinduc
phosphoryl
allow
homodimer
nuclear
import
activ
type
ifn
gene
ifna
ifnb
ikk
similar
abil
activ
abil
phosphoryl
ikba
inhibitor
nfkb
present
differ
may
import
instanc
delet
gene
lead
embryon
lethal
day
due
tnfinduc
apoptosi
b
r
c
innat
immun
system
form
first
line
defens
invad
pathogen
reli
major
part
activ
two
transcript
factor
nfkb
signal
pathway
activ
transcript
factor
intertwin
level
canon
ikb
kinas
ikka
ikkb
noncanon
ikkrel
kinas
ikk
recent
signific
progress
made
understand
function
mechan
action
ikk
immun
signal
addit
ikk
impact
cell
prolifer
transform
therebi
also
classifi
oncogen
studi
ikk
knockout
mice
illustr
key
role
ikk
inflammatori
metabol
diseas
review
highlight
mechan
ikk
impact
signal
pathway
involv
diseas
develop
discuss
potenti
novel
therapeut
target
elsevi
inc
right
reserv
liver
wherea
ikk
defici
mice
viabl
reason
differ
phenotyp
still
unclear
may
part
reflect
differenti
express
use
ikk
variou
cell
type
see
also
section
moreov
ikk
may
nonredund
function
signal
pathway
control
irf
canon
nfkb
activ
exampl
recent
publish
work
demonstr
specif
role
neg
regul
noncanon
nfkb
signal
b
cell
stimul
baff
associ
induc
mediat
phosphoryl
kinas
nik
lead
degrad
although
b
cell
express
ikk
nik
phosphoryl
highli
specif
sinc
ikk
share
substrat
consensu
phosphoryl
motif
substrat
specif
like
driven
recruit
ikk
discret
signal
complex
possibl
involv
specif
scaffold
protein
see
section
given
evergrow
number
ikk
interact
partner
substrat
local
kinas
activ
substrat
modif
could
effect
strategi
confer
ikk
specif
function
ikka
ikkb
constitut
express
cell
type
basal
ikk
express
observ
specif
tissu
pancrea
thymu
spleen
cell
type
tcell
peripher
blood
leukocyt
howev
cell
type
eg
fibroblast
ikk
rapidli
upregul
cytokin
eg
tnf
ifng
microbi
product
eg
lp
viral
rna
phorbol
ester
pma
therefor
also
call
induc
ikk
ikki
promot
ikk
gene
contain
two
put
nfkb
bind
site
one
shown
function
activ
well
seven
site
two
activ
whether
increas
ikk
express
induc
kinas
activ
current
still
unclear
recent
two
ikk
splice
variant
miss
amino
acid
amino
acid
ctermin
end
detect
human
peripher
blood
mononuclear
cell
splice
variant
ubiquit
express
mrna
level
protein
isoform
select
upregul
tnf
stimul
viru
infect
ikk
frequent
overexpress
number
human
cancer
particular
breast
ovarian
pancreat
cancer
implic
tumorigenesi
see
section
although
ikk
show
mani
overlap
activ
relev
innat
immun
inflamm
restrict
express
ikk
particular
interest
review
therefor
focu
ikk
mainli
refer
reason
comparison
identif
ikk
ikba
kinas
alway
controversi
sourc
mani
debat
evid
base
primarili
observ
overexpress
ikk
cultur
cell
lead
phosphoryl
ikba
one
phosphoacceptor
site
respect
drive
increas
ikba
turnov
howev
ikk
defici
mef
cell
display
normal
ikba
degrad
respons
tnf
lp
contradict
overexpress
data
nevertheless
tnf
lpsinduc
nfkb
depend
gene
express
abrog
absenc
ikk
therefor
believ
ikk
influenc
nfkb
signal
concomit
gene
express
downstream
ikba
fig
context
sever
studi
support
role
ikkemedi
phosphoryl
nfkb
subunit
express
specif
subset
nfkb
target
gene
respons
proinflammatori
signal
viral
infect
also
shown
activ
phosphoryl
serv
dock
site
bring
ikkeenzymat
activ
kbcontain
inflammatori
gene
promot
nucleu
enabl
ikk
phosphoryl
adjac
cjun
initi
nuclear
receptor
corepressor
clearanc
result
suggest
ikk
promot
exhibit
kb
site
close
proxim
eg
ino
may
regul
activ
initi
corepressor
turnov
besid
also
target
crel
nfkb
lead
nuclear
accumul
activ
nfkb
depend
gene
express
next
role
nfkb
signal
ikk
also
implic
signal
respons
viral
infect
sens
divers
receptor
rigi
lead
product
type
ifn
fig
constitut
express
cytoplasm
mani
cell
need
transcript
upregul
ikk
directli
phosphoryl
ctermini
result
homoand
heterodimer
transloc
nucleu
mass
spectrometri
pinpoint
redund
phosphoryl
site
ikk
upon
viral
infect
innat
immun
cell
ikk
defici
mef
cell
show
chang
activ
wherea
defici
mef
cell
show
reduc
activ
upon
trigger
howev
activ
complet
abolish
ikk
doubl
defici
mef
ikk
overexpress
kinas
dead
mutant
could
restor
activ
defici
cell
suggest
redund
kinas
although
ikk
seem
exert
overlap
function
activ
mechanist
differ
activ
ikk
follow
viru
infect
observ
eg
mitochondri
local
ikk
versu
cytoplasm
local
moreov
partial
differ
substrat
report
kinas
interest
note
tlr
adaptor
protein
recent
shown
abrog
ifn
product
prevent
ikk
phosphoryl
indic
kinas
also
differenti
regul
although
activ
sever
inflammatori
stimuli
activ
rigi
receptor
best
document
receptor
stimul
induc
recruit
specif
adaptor
protein
receptor
trif
mav
rigi
subsequ
adaptor
interact
ubiquitin
ligas
activ
ubiquitin
ligas
kinas
activ
nfkb
autoubiquitin
need
recruit
activ
ikk
later
time
point
presenc
ikk
mav
complex
eventu
lead
releas
shutdown
ifn
signal
consequ
protein
level
ikk
activ
regul
phosphoryl
singl
site
activ
loop
contrast
ikka
ikkb
requir
phosphoryl
two
site
ikka
ikkb
function
although
overexpress
studi
indic
role
autophosphoryl
activ
endogen
kinas
involv
autophosphoryl
inde
cell
treat
ikk
inhibitor
still
show
phosphoryl
ikk
respons
poli
c
lp
tnf
suggest
involv
kinas
clark
cowork
could
show
phosphoryl
impair
ikka
defici
cell
treat
ikk
inhibitor
indic
ikka
potenti
ikk
kinas
line
observ
tnfinduc
activ
seem
mediat
sole
canon
ikk
interestingli
activ
canon
ikk
pathway
result
nfkb
activ
activ
similar
canon
kinas
ikka
ikkb
requir
format
complex
adaptor
protein
nemo
also
ikk
activ
involv
specif
adaptor
protein
far
three
scaffold
protein
shown
bind
promot
phosphoryl
nak
associ
protein
tnf
receptorassoci
factor
traf
famili
memberassoci
nfkb
activ
tank
similar
nap
adaptor
sintbad
therefor
attract
idea
differ
scaffold
protein
might
assembl
distinct
ikk
complex
distinct
condit
provid
signal
specif
whether
scaffold
protein
assembl
heteroor
homodim
ikk
current
still
unknown
contrast
posit
regul
nfkb
depend
gene
express
latter
also
describ
neg
regul
nfkb
activ
respons
tnf
stimul
specif
shown
directli
phosphoryl
canon
ikk
outsid
activ
loop
restrict
activ
fig
interestingli
neg
regul
canon
ikk
impair
tankdefici
macrophag
use
cell
also
shown
tank
requir
nfkb
activ
respons
lp
via
trifdepend
pathway
mediat
interact
noncanon
ikk
canon
ikk
latter
like
involv
bind
tank
canon
ikk
adaptor
protein
nemo
togeth
find
demonstr
key
role
adaptor
protein
tank
enabl
canon
noncanon
ikk
regul
analog
nemo
one
expect
mechan
drive
activ
like
requir
differ
posttransl
modif
scaffold
protein
inde
ikk
depend
phosphoryl
polyubiquitin
tank
alreadi
describ
respons
lp
stimul
signific
still
unclear
multipl
neg
regulatori
mechan
place
avoid
excess
activ
ifn
product
exampl
deubiquitinas
duba
revers
ubiquitin
disconnect
substrat
ikk
also
deubiquitinas
cyld
neg
regul
rigi
induc
interferon
product
deubiquitin
rigi
convers
ikk
directli
phosphoryl
cyld
herebi
decreas
deubiquitin
potenti
increas
ikkeinduc
cell
transform
fig
see
section
other
shown
ubiquitinedit
enzym
conjunct
bind
protein
antagon
ikk
surprisingli
inhibit
independ
dub
function
recent
ubiquitin
ligas
trip
shown
neg
regul
activ
induc
proteosom
degrad
show
weak
activ
ikk
activ
trip
ikk
studi
interestingli
also
mani
virus
interfer
irf
pathway
antivir
ifn
product
level
ikk
andor
exampl
specif
viral
compon
disturb
interact
signal
protein
eg
ebola
viru
protein
protein
corona
viru
hepat
b
c
viru
altern
viral
protein
may
act
altern
substrat
ikk
therebi
target
kinas
degrad
eg
borna
diseas
viru
p
protein
paramyxoviru
v
protein
viru
adapt
emphas
import
noncanon
kinas
antivir
signal
ikk
activ
link
patholog
inflammatori
diseas
rheumatoid
arthriti
ra
instanc
ikk
constitut
express
phosphoryl
synovi
intim
line
ra
patient
result
uncontrol
product
proinflammatori
mediat
ifnb
matrix
metalloproteinas
chemokin
support
major
contribut
ikk
pathogenesi
ra
find
mice
defici
ikk
show
less
synovi
inflamm
passiv
kbxn
arthriti
model
due
lower
express
inflammatori
mediat
furthermor
ikk
singl
nucleotid
polymorph
associ
earli
stage
ra
genom
wide
associ
studi
reveal
ikk
suscept
locu
system
lupu
erythematosu
sle
type
ifn
play
crucial
role
comput
analysi
predict
proteinprotein
interact
also
pinpoint
ikk
potenti
therapeut
target
psoriasi
ikk
also
implic
pulmonari
inflamm
context
ikk
defici
mice
show
fewer
infiltr
neutrophil
diminish
express
proinflammatori
cytokin
chemokin
intranas
administr
surprisingli
model
ikk
defici
affect
nfkb
activ
reduc
map
kinas
signal
specif
ikk
shown
respons
phosphoryl
receptor
adaptor
therebi
activ
pathway
lead
increas
map
kinas
activ
leav
axi
eman
undisturb
increas
map
kinas
activ
led
increas
chemokin
mrna
stabil
contribut
increas
chemokin
product
neutrophil
infiltr
lung
role
ikk
regul
respons
also
illustr
recent
find
ikk
promot
aktmtor
signal
pathway
mediat
induc
mainten
phosphoryl
inactiv
taken
togeth
mani
studi
indic
import
role
ikk
pathophysiolog
inflammatori
diseas
mainli
regul
nfkb
ifn
respons
ikk
might
also
potenti
target
treat
inflammatori
pain
inflammatori
pain
model
hind
paw
inflamm
evok
inject
zymosan
formalin
ikkedefici
mice
exhibit
significantli
reduc
nocicept
behavior
comparison
wild
type
mice
indic
ikk
contribut
develop
inflammatori
hyperalgesia
time
provok
nfkb
activ
nocicept
neuron
neuron
involv
percept
pain
reduc
reflect
lower
inflammatori
gene
express
interest
process
independ
type
ifn
respons
suggest
ikk
promot
inflammatori
hyperalgesia
mere
activ
nfkb
pathway
final
ikk
report
import
link
inflamm
obes
obes
mice
major
risk
develop
inflammatori
metabol
diseas
type
diabet
fact
obes
mimic
perman
lowgrad
inflammatori
condit
due
dietari
fatti
acid
recognit
hypoxia
elev
nfkb
activ
obes
mice
drive
increas
ikk
express
liver
adipocyt
adipos
tissu
macrophag
furthermor
mice
defici
ikk
found
protect
high
fat
dietinduc
obes
show
less
chronic
liver
inflamm
hepat
steatosi
insulin
resist
event
regul
chang
express
regulatori
protein
enzym
involv
glucos
lipid
metabol
decreas
product
proinflammatori
cytokin
protein
involv
insulin
resist
transfect
cultur
adipocyt
hepatoma
cell
ikk
induc
similar
chang
suggest
direct
role
ikk
regul
hepat
inflamm
howev
contradictori
result
report
anoth
group
show
differ
ikk
knockout
wild
type
mice
model
high
fat
dietinduc
obes
insulin
resist
therefor
work
need
defin
precis
role
ikk
develop
metabol
diseas
ikk
associ
initi
progress
multipl
cancer
might
function
oncogen
malign
transform
instanc
sever
breast
cancer
cell
line
primari
human
breast
tumor
express
high
level
ikk
increas
ikk
express
due
till
unknown
mutat
regul
ikk
transcript
level
amplif
region
compris
ikbk
locu
ectop
express
ikk
immort
mammari
epitheli
cell
level
found
human
cancer
cell
render
tumorigen
confirm
allel
amplifi
breast
cancer
specimen
transform
high
ikk
express
often
associ
accumul
crel
nfkb
subunit
nucleu
eg
primari
breast
tumor
ikk
silenc
sever
breast
cancer
cell
line
shown
reduc
nfkb
activ
cell
prolifer
similarli
introduc
kinas
inact
ikk
mutant
ikk
breast
cancer
cell
exert
domin
neg
effect
endogen
ikk
reduc
nfkb
depend
gene
express
eg
cyclin
relb
demonstr
necess
ikk
catalyt
activ
recent
confirm
demonstr
requir
ikkemedi
phosphoryl
tumor
suppressor
cyld
prevent
deubiquitin
activ
nfkb
signal
protein
nemo
fig
moreov
ikk
also
activ
ubiquitin
ligas
direct
phosphoryl
result
increas
ubiquitin
togeth
event
lead
enhanc
nfkb
activ
promot
surviv
transform
prolifer
mammari
epitheli
cell
fig
furthermor
ikk
well
may
contribut
enhanc
nfkb
activ
tumorigenesi
directli
phosphoryl
nfkb
describ
phosphoryl
akt
phosphoryl
activ
addit
elev
ikk
level
also
associ
activ
differ
primari
tumor
cell
line
deriv
divers
cancer
like
lung
breast
carcinoma
may
also
contribut
oncogen
activ
ikk
suppress
affect
ikkeinduc
cell
transform
oncogen
potenti
ikk
seem
independ
signal
function
recent
human
ovarian
cancer
cell
line
primari
tumor
also
shown
elev
level
activ
ikk
associ
lower
overal
surviv
rate
furthermor
alter
ikk
associ
latestag
highgrad
tumor
suggest
role
ikk
ovarian
tumor
progress
rather
tumor
initi
final
ikk
also
describ
oncogen
prostat
oesophag
squamou
cell
carcinoma
increas
level
differ
nfkb
famili
member
clear
cell
renal
cell
carcinoma
overexpress
ikk
tumor
cell
induc
cell
surviv
cell
transform
prolifer
differ
mechan
involv
ikk
mediat
phosphoryl
specif
substrat
ikk
either
directli
indirectli
via
akt
phosphoryl
activ
phosphoryl
nfkb
lead
increas
nfkb
depend
gene
express
ikk
also
phosphoryl
inactiv
tumor
suppressor
cyld
prevent
cyld
deubiquitin
specif
substrat
nfkb
signal
pathway
addit
phosphoryl
activ
ubiquitin
ligas
activ
cyld
phosphoryl
thu
increas
ubiquitindepend
nfkb
signal
ikk
also
directli
phosphoryl
increas
gene
activ
potenti
high
level
ikk
coincid
resist
well
establish
chemotherapeut
also
case
elev
nfkb
activ
known
contribut
cancer
cell
surviv
reduc
sensit
chemotherapeut
agent
ioniz
radiat
unfortun
breast
cancer
cell
ikk
inactiv
retain
resist
chemotherapeut
despit
lower
nfkb
activ
suggest
addit
mechan
must
involv
regul
cell
death
final
ikk
also
accumul
subnuclear
promyelocyt
leukemia
pml
bodi
upon
genotox
stress
undergo
sumoyl
lead
activ
ultim
result
nfkb
mediat
antiapoptot
respons
respect
worthwhil
mention
sever
glioma
cell
line
human
primari
glioma
tissu
exhibit
elev
level
ikk
less
sensit
dna
damageinduc
apoptosi
suppress
ikk
howev
render
cell
sensit
confirm
prosurviv
function
role
ikk
develop
inflammatori
metabol
diseas
well
cancer
indic
potenti
ikk
therapeut
target
far
small
molecul
inhibitor
ikk
describ
first
ikk
inhibitor
market
suppress
ikk
activ
nanomolar
concentr
vitro
specif
howev
issu
sinc
origin
develop
inhibitor
protein
kinas
later
found
also
inhibit
ikk
moreov
show
offtarget
effect
toward
sever
kinas
includ
jnk
map
kinas
modifi
version
longer
inhibit
jnk
map
kinas
still
interfer
activ
recent
seri
azabenzimidol
deriv
pyrimidin
improv
kinas
select
druglik
properti
describ
howev
compound
still
inhibit
ikk
slightli
higher
potenc
mice
pyrimidin
significantli
inhibit
lpsinduc
releas
ifnb
although
toxic
observ
higher
dose
worth
mention
also
number
natur
occur
compound
polyphenol
lutolin
quercetin
antiinflammatori
properti
shown
target
activ
ikk
describ
gener
specif
polyphenol
low
multipl
target
develop
specif
better
ikk
inhibitor
may
enabl
recent
elucid
substrat
specif
ikk
studi
demonstr
consensu
phosphoryl
motif
ikk
differ
ikkb
ident
suggest
develop
ikk
inhibitor
target
may
difficult
nevertheless
highthroughput
screen
use
specif
substrat
peptid
result
sever
lead
molecul
show
select
either
ikk
howev
ikk
show
mani
overlap
function
oncogen
inflammatori
signal
pathway
like
therapeut
effect
ikk
specif
inhibitor
may
hamper
redund
activ
therefor
least
case
inhibit
activ
kinas
may
better
therapeut
approach
final
overexpress
ikk
link
tumorigenesi
therapeut
approach
would
reduc
ikk
express
normal
level
may
valid
altern
therefor
fundament
research
molecular
mechan
regul
ikk
express
may
boost
develop
ikk
target
drug
potenti
valu
ikk
therapeut
target
antiinflammatori
anticanc
therapi
requir
investig
mechan
pathway
involv
pharmaceut
industri
activ
develop
ikka
ikkb
inhibitor
novel
antiinflammatori
agent
far
limit
success
sinc
nfkb
mediat
number
physiolog
function
nonselect
complet
inhibit
nfkb
pathway
may
lead
seriou
sideeffect
also
illustr
fact
ikka
ikkb
nemodefici
mice
die
embryon
develop
perinat
compound
select
repress
activ
nfkb
respons
specif
receptor
express
specif
subset
nfkb
depend
gene
would
associ
fewer
side
effect
therefor
ikk
could
well
target
great
clinic
valu
support
fact
ikk
knockout
mice
contrast
ikka
ikkb
knockout
mice
viabl
fertil
sinc
knockout
mice
also
die
embryon
challeng
develop
ikk
specif
inhibitor
target
context
also
import
determin
rel
contribut
ikk
differ
pathway
eg
nfkb
versu
irf
pathophysiolog
process
modul
ikk
express
activ
distinct
cell
type
tissu
mean
condit
knockout
mice
therefor
high
valu
addit
knowledg
differ
ikk
substrat
physiolog
relev
phosphoryl
may
help
predict
effici
side
effect
ikk
inhibitor
relationship
canon
noncanon
ikk
signal
pathway
also
open
line
investig
particular
neg
regulatori
effect
ikk
canon
ikk
could
suggest
inhibit
ikk
may
actual
proinflammatori
effect
context
detail
understand
molecular
mechan
involv
counterregul
ikk
famili
could
help
mani
player
involv
eg
tank
nemo
connect
ikk
ikkrel
kinas
phosphoryl
modifi
differ
type
ubiquitin
chain
consequ
modif
fulli
clear
ikk
also
believ
form
distinct
complex
differ
adaptor
protein
tank
sintbad
could
perform
differ
function
futur
studi
exist
function
ikk
complex
consist
distinct
ikk
adaptor
protein
therefor
high
interest
may
allow
select
ikk
target
studi
may
also
help
explain
stimuli
eg
tnf
activ
without
induc
phosphoryl
wherea
stimuli
eg
lp
viral
rna
activ
pathway
via
strong
induc
ikk
express
overexpress
multipl
tumor
also
worthwhil
examin
upstream
signal
regul
ikk
express
determin
ikk
stabil
ikk
overexpress
suffici
oncogen
context
gener
eg
mammari
tissu
specif
ikk
transgen
mice
may
inform
summari
gener
exploit
ikk
specif
inhibitor
condit
knockoutknockintransgen
mice
ikk
regul
substrat
like
give
answer
mani
mention
question
eventu
could
lead
use
ikk
specif
inhibitor
success
treatment
autoimmun
obes
diabet
certain
cancer
foundat
cancer
strateg
basic
research
programm
iwt
hercul
goa
groupid
mrp
initi
ghent
univers
lv
hold
fwo
postdoctor
fellowship
